NCLEX vs. FECGX
NCLEX (Nicholas Limited Edition Fund) and FECGX (Fidelity Small Cap Growth Index Fund) are both Small Cap Growth Equities funds. Over the past 5 years, NCLEX returned 0.04%/yr vs 6.59%/yr for FECGX. Their correlation of 0.90 suggests significant overlap in exposure. NCLEX charges 0.85%/yr vs 0.05%/yr for FECGX.
Performance
NCLEX vs. FECGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NCLEX achieves a -0.59% return, which is significantly lower than FECGX's 18.62% return.
NCLEX
- 1D
- 0.28%
- 1M
- 6.43%
- 6M
- -5.41%
- YTD
- -0.59%
- 1Y
- -5.55%
- 3Y*
- 0.82%
- 5Y*
- 0.04%
- 10Y*
- 7.71%
FECGX
- 1D
- 0.14%
- 1M
- 0.35%
- 6M
- 10.07%
- YTD
- 18.62%
- 1Y
- 32.32%
- 3Y*
- 16.53%
- 5Y*
- 6.59%
- 10Y*
- —
NCLEX vs. FECGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NCLEX Nicholas Limited Edition Fund | -0.59% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 5.09% |
FECGX Fidelity Small Cap Growth Index Fund | 18.62% | 13.04% | 15.26% | 18.90% | -26.17% | 2.83% | 34.41% | 7.11% |
Correlation
The correlation between NCLEX and FECGX is 0.70, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.70 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.84 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.90 |
Correlation (All Time) Calculated using the full available price history since Jul 17, 2019 | 0.90 |
Over the past year, the correlation between NCLEX and FECGX has dropped to 0.70 - well below their long-term average of 0.90, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NCLEX vs. FECGX — Risk / Return Rank
NCLEX
FECGX
NCLEX vs. FECGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nicholas Limited Edition Fund (NCLEX) and Fidelity Small Cap Growth Index Fund (FECGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NCLEX | FECGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.82 | ||
| Sortino ratioReturn per unit of downside risk | -2.45 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.26 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.22 | 2.30 | -2.53 |
| Martin ratioReturn relative to average drawdown | -0.44 | 8.21 | -8.65 |
Loading charts...
Drawdowns
NCLEX vs. FECGX - Drawdown Comparison
The maximum NCLEX drawdown since its inception was -48.68%, which is greater than FECGX's maximum drawdown of -41.85%. Use the drawdown chart below to compare losses from any high point for NCLEX and FECGX.
Loading charts...
Drawdown Indicators
| NCLEX | FECGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.68% | -41.85% | -6.83% |
Max Drawdown (1Y)Largest decline over 1 year | -20.88% | -14.81% | -6.07% |
Max Drawdown (3Y)Largest decline over 3 years | -28.50% | -28.45% | -0.05% |
Max Drawdown (5Y)Largest decline over 5 years | -28.50% | -40.34% | +11.84% |
Max Drawdown (10Y)Largest decline over 10 years | -35.79% | — | — |
Current DrawdownCurrent decline from peak | -16.84% | -2.97% | -13.87% |
Average DrawdownAverage peak-to-trough decline | -8.31% | -15.52% | +7.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.52% | 4.15% | +6.37% |
Volatility
NCLEX vs. FECGX - Volatility Comparison
The current volatility for Nicholas Limited Edition Fund (NCLEX) is 4.54%, while Fidelity Small Cap Growth Index Fund (FECGX) has a volatility of 5.33%. This indicates that NCLEX experiences smaller price fluctuations and is considered to be less risky than FECGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NCLEX | FECGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.54% | 5.33% | -0.79% |
Volatility (6M)Calculated over the trailing 6-month period | 12.62% | 16.79% | -4.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.07% | 22.18% | -5.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.60% | 24.68% | -5.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.19% | 27.13% | -7.94% |
NCLEX vs. FECGX - Expense Ratio Comparison
NCLEX has a 0.85% expense ratio, which is higher than FECGX's 0.05% expense ratio.
Dividends
NCLEX vs. FECGX - Dividend Comparison
NCLEX's dividend yield for the trailing twelve months is around 7.58%, more than FECGX's 0.46% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FECGX Fidelity Small Cap Growth Index Fund | 0.46% | 0.54% | 1.25% | 0.81% | 0.80% | 3.43% | 1.00% | 0.29% | 0.00% | 0.00% | 0.00% | 0.00% |
NCLEX Nicholas Limited Edition Fund | 7.58% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
NCLEX and FECGX have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FECGX has higher volatility (5.33%) compared to NCLEX (4.54%). In terms of maximum drawdown, NCLEX dropped -48.68% vs FECGX's -41.85%.
FECGX currently has the higher Sharpe Ratio (1.54 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NCLEX and FECGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer